Scientists discover the nutrient that can supercharge cellular energy
Researchers at the University of Cologne discovered that leucine, an amino acid in protein-rich foods, enhances mitochondrial energy production by protecting key proteins from degradation, potentially offering new avenues for treating metabolic diseases and cancer. The study, published in *Nature Cell Biology*, also identified SEL1L as a regulatory protein in this process, with implications for cellular health and disease.
Researchers at the University of Cologne have identified leucine as a nutrient that boosts mitochondrial energy production by preventing the breakdown of essential proteins on the outer mitochondrial membrane. The study, led by Professor Dr. Thorsten Hoppe and published in *Nature Cell Biology*, reveals that leucine stabilizes these proteins, allowing cells to generate energy more efficiently. Leucine, an essential amino acid found in foods like meat, dairy, beans, and lentils, is already known for its role in protein synthesis. The new research shows it also acts as a regulator of mitochondrial function by suppressing the activity of SEL1L, a protein involved in degrading damaged mitochondrial components. This suppression preserves energy-producing proteins, improving cellular energy output during high-demand periods. The team demonstrated that leucine’s influence on mitochondrial efficiency could have broader biological effects. Experiments on the roundworm *Caenorhabditis elegans* showed that disrupted leucine metabolism impaired mitochondrial function and fertility. Additionally, human lung cancer cells with mutations affecting leucine metabolism exhibited enhanced survival, suggesting a potential link between this pathway and cancer progression. While the findings highlight leucine’s role in optimizing cellular energy, the researchers caution that excessive modulation could disrupt SEL1L’s protective functions, leading to long-term cellular damage. The discovery opens new possibilities for exploring dietary interventions in metabolic diseases and cancer therapies, though further study is needed to understand the full implications.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.